Regulation of T cell apoptosis via T cell receptors and steroid receptors

Stem Cells
M IwataA Asada

Abstract

Less than 5% of immature CD4/CD8 double-positive (DP) thymocytes are positively selected to survive and differentiate into single-positive CD4 and CD8 T cells, while self-reactive DP thymocytes undergo apoptosis (negative selection). Both positive and negative selection events are active processes that involve signaling through the T cell receptors (TCRs) and through some accessory molecules. The two events differ quantitatively in the strength of the interaction between TCR and peptide/major histocompatibility complex molecules. We established an in vitro model of positive selection that can be analyzed quantitatively. Positive selection is likely to inhibit glucocorticoid-induced apoptosis in DP thymocytes. Proper crosslinking of TCR together with CD4, CD8, or LFA-1 inhibits the death, and its inhibitory activity is mimicked by proper combinations of ionomycin, a calcium ionophore, and phorbol myristate acetate (PMA), a protein kinase C (PKC) activator. The drug concentrations are within narrow ranges, and are lower than those which are required for the proliferation of mature T cells. Transient stimulation with the combinations of ionomycin and PMA induces differentiation and commitment of isolated DP thymocytes to the CD4 o...Continue Reading

References

Jan 1, 1991·International Journal of Immunopharmacology·M J StaruchF J Dumont
Jun 1, 1989·The Journal of Experimental Medicine·J C Zuñiga-PflückerA M Kruisbeek
Aug 24, 1972·The New England Journal of Medicine·H N Claman
Feb 1, 1980·Journal of Steroid Biochemistry·F HomoC Evrard
Jan 1, 1995·The Journal of Experimental Medicine·M R AldersonD H Lynch
Feb 2, 1995·Nature·J DheinP H Krammer
Nov 1, 1995·The Journal of Experimental Medicine·T M FoyR J Noelle
Jan 1, 1995·Current Topics in Microbiology and Immunology·M Iwata
May 1, 1993·International Immunology·L A JonesA M Kruisbeek
May 19, 1995·Cell·J L Cleveland, J N Ihle
Jan 1, 1994·Immunology Today·T M Buttke, P A Sandstrom
Jun 1, 1994·The Journal of Experimental Medicine·M S VacchioJ D Ashwell
May 1, 1993·The Journal of Experimental Medicine·J A GonzaloG Kroemer
Jun 13, 1996·Nature·S M AlamN R Gascoigne
Apr 1, 1996·The Journal of Experimental Medicine·T ZhouJ D Mountz

❮ Previous
Next ❯

Citations

May 16, 1998·European Journal of Immunology·H E PorrittJ J Owen
Aug 6, 2000·Cell and Tissue Research·R D Medh, E B Thompson
Dec 1, 2005·Age·Emma T Lavoie
Oct 17, 1998·Immunopharmacology·K AndréauA Adam
Oct 8, 1999·Trends in Endocrinology and Metabolism : TEM·E B Thompson
Aug 1, 2009·Natural Product Reports·Zhenlei SongRichard P Hsung
Jan 9, 2014·International Journal of Biological Macromolecules·Yuwei ZhaoShaoning Yu
Nov 9, 2001·Biochemical and Biophysical Research Communications·S AdachiM Iwata
Jun 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·C A Jamieson, K R Yamamoto
Oct 15, 2005·Journal of Immunotherapy·Christian S HinrichsNicholas P Restifo
Aug 1, 2002·Leukemia & Lymphoma·R LerzaE Arboscello
Sep 27, 2012·Parasite Immunology·M DoligalskaK Donskow-Łysoniewska
Feb 16, 2005·Journal of Neuroimmunology·Irena P ZivkovićMileva V Mićić
Jul 12, 2005·General and Comparative Endocrinology·B Hareramadas, U Rai
Oct 21, 2003·Autonomic & Autacoid Pharmacology·F MigniniF Amenta
Jun 27, 1998·Biochemical and Biophysical Research Communications·T KuwataM Iwata
Sep 4, 2009·Journal of Molecular Signaling·Yasuko HirakawaRheem D Medh
Jun 24, 2009·Experimental Biology and Medicine·Zorica Stojić-VukanićGordana Leposavić
May 9, 2000·The Journal of Biological Chemistry·S AdachiM Iwata
Oct 4, 2000·Physiological Reviews·F Rusnak, P Mertz
Nov 18, 2006·Molecular and Cellular Biochemistry·Soha Abdelkawi AbdelwahabHisatake Kondo
Feb 29, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·R DimriJ Shoham
Jan 7, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jairo OlivaresJohn Nemunaitis
Nov 12, 2019·Veterinary Immunology and Immunopathology·Harry CridgeTodd M Archer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.